Noninvasive Diagnosis of Cellular and Antibody-Mediated Rejection by Perforin and Granzyme B in Renal Allografts
- 1 October 2006
- journal article
- Published by Elsevier in Human Immunology
- Vol. 67 (10) , 777-786
- https://doi.org/10.1016/j.humimm.2006.07.006
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Molecular Diagnosis of Renal-Allograft Rejection: Correlation with Histopathologic Evaluation and Antirejection-Therapy ResistanceTransplantation, 2004
- Biomarkers and Surrogate Endpoints in Renal Transplantation: Present Status and Considerations for Clinical Trial DesignAmerican Journal of Transplantation, 2004
- Serial Peripheral Blood Perforin and Granzyme B Gene Expression Measurements for Prediction of Acute Rejection in Kidney Graft RecipientsAmerican Journal of Transplantation, 2003
- Protocol biopsies should be part of the routine management of kidney transplant recipientsAmerican Journal of Kidney Diseases, 2002
- Functional significance of the perforin/granzyme cell death pathwayNature Reviews Immunology, 2002
- Cytotoxic T lymphocytes: all roads lead to deathNature Reviews Immunology, 2002
- Granzyme B, fas-ligand and perforin expression during acute cellular rejection episodes after kidney transplantation: comparison between blood and renal aspiratesTransplantation Proceedings, 2002
- Noninvasive Diagnosis of Renal-Allograft Rejection by Measurement of Messenger RNA for Perforin and Granzyme B in UrineNew England Journal of Medicine, 2001
- Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996New England Journal of Medicine, 2000
- MOLECULAR EXECUTORS OF CELL DEATH-DIFFERENTIAL INTRARENAL EXPRESSION OF Fas LIGAND, Fas, GRANZYME B, AND PERFORIN DURING ACUTE AND/OR CHRONIC REJECTION OF HUMAN RENAL ALLOGRAFTS1,2Transplantation, 1996